Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Hamilton, T

Class:IdPerson:570882
_displayNameHamilton, T
_timestamp2010-04-09 15:59:08
created[InstanceEdit:570884] Shamovsky, V, 2010-04-09
firstnameThomas
initialT
surnameHamilton
(author)[LiteratureReference:570877] Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control
[LiteratureReference:4613325] Interleukin 1alpha-induced NFkappaB activation and chemokine mRNA stabilization diverge at IRAK1
[LiteratureReference:8980037] The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation
[LiteratureReference:8980127] Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)
[LiteratureReference:8980512] The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease
[Change default viewing format]
No pathways have been reviewed or authored by Hamilton, T (570882)